Press Releases
Growth in the Breast Cancer Drug Market Through 2021 Will Be Driven by New Entrants from Roche/Genentech and Novartis in Select Market Segments and...
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2021 the uptake of three new market entrants, Roche/Genentech’s Perjeta (pertuzumab) and trastuzumab-DM1 (T-DM1), and Novartis’s Afinitor (everolimus) will...
Press Releases
New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) , today announced that the new BD MAX™ MRSA molecular test has received a Moderate Complexity rating under the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88). ...
Press Releases
Quintiles Acquires Expression Analysis, Premier Provider of Genomics Services, to Advance Personalized Medicine
To help biopharmaceutical companies dramatically improve drug development productivity and deliver greater value, Quintiles today announced the acquisition of Expression Analysis, Inc. (EA), a premier provider of genomics testing and analysis to biopharma, academic, government and non-profit customers....
Press Releases
Zylast™ to Present Benefits of Its Broad Spectrum Antimicrobial Products At Cruise Ship Healthcare Conference
Zylast™, a marketer of a full line of antiseptic products, announced today that an infectious disease specialist will make a presentation titled "The Benefits of a Broad Spectrum Persistent Antimicrobial" at the 12th Annual Institute of Cruise Ship...
Press Releases
Andante Medical Devices, Inc. Launches the iSmartStep® Basic for Use with iPhone & iPod touch into the Home Care Physical Therapy Market
ANDANTE MEDICAL DEVICES, INC.announced today the immediate availability of their SmartStep® App for iPhone and iPod touch. The SmartStep App is used in conjunction with iSmartStep® Basic, a Functional Feedback Therapy (FFT) device that will...
Press Releases
Ferrer submits IND for Arasertaconazole nitrate, a safe, fast-acting topical antifungal in development for Vulvovaginal Candidiasis
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to commercialisation, announces today that it has filed an IND for its topical antifungal agent Arasertaconazole nitrate. The agent has recently demonstrated...
Press Releases
Exactech Announces Investor Presentation at Canaccord Genuity Growth Conference
Exactech, Inc., a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials will update investors at the 2012 Canaccord Genuity Growth Conference in Boston on Tuesday, August 14, 2012. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read